PRESENCE OF THE 2 GROWTH-HORMONE RECEPTOR MESSENGER-RNA ISOFORMS IN HUMAN BREAST-CANCER

被引:0
作者
DECOUVELAERE, C
PEYRAT, JP
BONNETERRE, J
DJIANE, J
JAMMES, H
机构
[1] INRA,UNITE ENDOCRINOL MOLEC,F-78350 JOUY EN JOSAS,FRANCE
[2] CTR OSCAR LAMBRET,F-59020 LILLE,FRANCE
来源
CELL GROWTH & DIFFERENTIATION | 1995年 / 6卷 / 04期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the present study, we have investigated specific growth hormone (CH) receptor gene expression in breast cancer cell lines and tissues. By Northern blot analysis, using a human GH receptor cDNA probe, the classically observed 4.7-kilobase GH receptor mRNA was evidenced in 2 of 29 cancer biopsies and in the MCF7 and T47-D cell lines. Reverse transcription coupled to PCR was used to amplify the GH receptor sequence encompassing a part of the extracellular domain as well as the transmembrane domain. An amplification product of the expected size (456 base pairs) was observed in 28 of 29 breast biopsies and in all the breast cancer cell lines studied (T47-D, MCF7, MDA-MB-231, and BT-20). The reverse transcription-PCR product was shown to be specific by Southern blot hybridization with the GH receptor cDNA probe and by specific cleavage of the amplified products with restriction enzymes. For the first time, the expression of GH receptor gene in breast cancer cell lines and biopsies is demonstrated in this study, suggesting a GH-specific action in tumor development. Additionally, the two isoforms of the human GH receptor (hGHR) mRNA, one containing exon 3 (hGHR-wt mRNA) and one excluding exon 3 (hGHR-d3 mRNA), were found to be expressed independently or simultaneously (29 tumors analyzed). The presence of hGHR-d3 mRNA appears to be patient specific, as demonstrated by comparing the expression pattern of both mRNAs between tumor biopsy and lymphocytes of the same patient.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 42 条
  • [1] IDENTIFICATION OF JAK2 AS A GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE
    ARGETSINGER, LS
    CAMPBELL, GS
    YANG, XN
    WITTHUHN, BA
    SILVENNOINEN, O
    IHLE, JN
    CARTERSU, C
    [J]. CELL, 1993, 74 (02) : 237 - 244
  • [2] TAMOXIFEN PLUS BROMOCRIPTINE VERSUS TAMOXIFEN PLUS PLACEBO IN ADVANCED BREAST-CANCER - RESULTS OF A DOUBLE-BLIND MULTICENTER CLINICAL-TRIAL
    BONNETERRE, J
    MAURIAC, L
    WEBER, B
    ROCHE, H
    FARGEOT, P
    TUBIANAHULIN, M
    SEVIN, M
    CHOLLET, P
    CAPPELAERE, P
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1851 - 1853
  • [3] BIOLOGICAL AND CLINICAL ASPECTS OF PROLACTIN RECEPTORS (PRL-R) IN HUMAN BREAST-CANCER
    BONNETERRE, J
    PEYRAT, JP
    BEUSCART, R
    DEMAILLE, A
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) : 977 - 981
  • [4] BONNETERRE J, 1987, CANCER RES, V47, P4724
  • [5] BONNETERRE J, 1985, BREAST DIS SENOLOGIA, V1, P3
  • [6] BONNETERRE J, 1990, REV ENDOCRINE RELATE, V35, P25
  • [7] IDENTIFICATION OF A CDNA-ENCODING A LONG FORM OF PROLACTIN RECEPTOR IN HUMAN HEPATOMA AND BREAST-CANCER CELLS
    BOUTIN, JM
    EDERY, M
    SHIROTA, M
    JOLICOEUR, C
    LESUEUR, L
    ALI, S
    GOULD, D
    DJIANE, J
    KELLY, PA
    [J]. MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) : 1455 - 1461
  • [8] BOUTIN JM, 1988, CELL, V5, P69
  • [9] PROLACTIN RECEPTOR GENE-EXPRESSION IN THE RABBIT - IDENTIFICATION, CHARACTERIZATION AND TISSUE DISTRIBUTION OF SEVERAL PROLACTIN RECEPTOR MESSENGER-RNAS ENCODING A UNIQUE PRECURSOR
    DUSANTERFOURT, I
    GAYE, P
    BELAIR, L
    PETRIDOU, B
    KELLY, PA
    DJIANE, J
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1991, 77 (1-3) : 181 - 192
  • [10] ELEVATED GROWTH-HORMONE LEVELS IN SERA FROM BREAST-CANCER PATIENTS
    EMERMAN, JT
    LEAHY, M
    GOUT, PW
    BRUCHOVSKY, N
    [J]. HORMONE AND METABOLIC RESEARCH, 1985, 17 (08) : 421 - 424